Literature DB >> 1776880

IgG subclass specific antibody response in recurrent bronchitis.

F de Baets1, R Pauwels, I Schramme, J Leroy.   

Abstract

The IgG subclass specific immune response against pneumococcal type 3 polysaccharide antigen before and after immunisation in healthy children and children with recurrent bronchitis was studied. Recurrent bronchitis was defined as three or more episodes a year, during at least two consecutive years, of bronchopulmonary infection, productive cough with or without fever, and/or diffuse rales by physical examination. Twenty five patients and 15 healthy children were selected. The patient group had lower concentrations of IgG1 and IgG2 specific pneumococcal antibodies compared with healthy children, regardless of whether or not the total IgG2 concentration was low. The children with recurrent bronchitis showed a greater increase in IgG1 and IgG2 antibodies after immunisation than the controls. It is concluded that children with recurrent bronchitis show a decreased humoral immune response to pneumococcal type 3 polysaccharide antigen. This finding suggests that a defect in the humoral immune response against polysaccharide antigens is an important cause of recurrent bronchitis in childhood.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1776880      PMCID: PMC1793374          DOI: 10.1136/adc.66.12.1378

Source DB:  PubMed          Journal:  Arch Dis Child        ISSN: 0003-9888            Impact factor:   3.791


  26 in total

1.  A test for concentration of electrolytes in sweat in cystic fibrosis of the pancreas utilizing pilocarpine by iontophoresis.

Authors:  L E GIBSON; R E COOKE
Journal:  Pediatrics       Date:  1959-03       Impact factor: 7.124

2.  Serum IgE levels in healthy children quantified by a sandwich technique (PRIST).

Authors:  N M Kjellman; S G Johansson; A Roth
Journal:  Clin Allergy       Date:  1976-01

3.  National survey of prevalence of asthma among children in the United States, 1976 to 1980.

Authors:  P J Gergen; D I Mullally; R Evans
Journal:  Pediatrics       Date:  1988-01       Impact factor: 7.124

4.  Serum immunoglobulins. I. Levels in normal children and in uncomplicated childhood allergy.

Authors:  R H Buckley; S C Dees; W M O'Fallon
Journal:  Pediatrics       Date:  1968-03       Impact factor: 7.124

5.  Patients with Igg subclass and/or selective antibody deficiency to polysaccharide antigens: initiation of a controlled clinical trial of intravenous immune globulin.

Authors:  A P Knutsen
Journal:  J Allergy Clin Immunol       Date:  1989-10       Impact factor: 10.793

6.  Natural infection of man with group A streptococci. Levels; restriction in class, subclass, and type; and clonal appearance of polysaccharide-group-specific antibodies.

Authors:  W F Riesen; F Skvaril; D G Braun
Journal:  Scand J Immunol       Date:  1976       Impact factor: 3.487

7.  Serum IgG subclasses in chronic and recurrent respiratory infections.

Authors:  P J Stanley; G Corbo; P J Cole
Journal:  Clin Exp Immunol       Date:  1984-12       Impact factor: 4.330

8.  IgG2 subclass restriction of antibody to pneumococcal polysaccharides.

Authors:  D J Barrett; E M Ayoub
Journal:  Clin Exp Immunol       Date:  1986-01       Impact factor: 4.330

9.  Selective defect in the antibody response to Haemophilus influenzae type b in children with recurrent infections and normal serum IgG subclass levels.

Authors:  D M Ambrosino; D T Umetsu; G R Siber; G Howie; T A Goularte; R Michaels; P Martin; P H Schur; J Noyes; G Schiffman
Journal:  J Allergy Clin Immunol       Date:  1988-06       Impact factor: 10.793

10.  Studies on human antibodies. VI. Selective variations in subgroup composition and genetic markers.

Authors:  W J Yount; M M Dorner; H G Kunkel; E A Kabat
Journal:  J Exp Med       Date:  1968-03-01       Impact factor: 14.307

View more
  1 in total

Review 1.  The Clinical Utility of Measuring IgG Subclass Immunoglobulins During Immunological Investigation for Suspected Primary Antibody Deficiencies.

Authors:  Antony R Parker; Markus Skold; David B Ramsden; J Gonzalo Ocejo-Vinyals; Marcos López-Hoyos; Stephen Harding
Journal:  Lab Med       Date:  2017-11-08
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.